HCV Kinetic Models and Their Implications in Drug Development

E-ISSN： 2163-8306|4|4|231-242

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.4, Iss.4, 2015-04, pp. : 231-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Interactions at the Renal Level: Implications for Drug Development

By Bonate P.L. Reith K. Weir S.

Clinical Pharmacokinetics, Vol. 34, Iss. 5, 1998-05 ,pp. : 375-404

Adis International

Access to resources Recommend Favorite

Major models of HCV infection

By Lagaye Sylvie Shen Hong Rousseau Géraldine Pol Stanislas

Future Virology, Vol. 8, Iss. 5, 2013-05 ,pp. : 493-506

Future Medicine

Access to resources Recommend Favorite

Tuberculosis susceptibility – implications for drug development and therapy

By Snell Noel J C

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1455-1460

Informa Healthcare

Access to resources Recommend Favorite

Systems Biology of Apoptosis and Survival: Implications for Drug Development

Current Pharmaceutical Design, Vol. 17, Iss. 3, 2011-01 ,pp. : 190-203

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models of hyperfunctioning parathyroid diseases for drug development

By Imanishi Yasuo Inaba Masaaki Kawata Takehisa Nishizawa Yoshiki

Expert Opinion on Drug Discovery, Vol. 4, Iss. 7, 2009-07 ,pp. : 727-740

Informa Healthcare

Access to resources Recommend Favorite